US Launches Trade Investigation into Germany's Drug Pricing Practices

The United States has commenced a Section 301 trade investigation targeting Germany's policies on drug pricing. While no specific tariffs have been announced yet, experts caution that such trade disputes often expand beyond their initial industry. This could potentially lead to broader economic implications between the two nations.